[1] WEIR H K, THOMPSON T D, STEWART S L, et al. Cancer incidence projections in the United States between 2015 and 2050[J]. Prev Chronic Dis, 2021, 18: E59.
[2] SWANTON C, BERNARD E, ABBOSH C, et al. Embracing cancer complexity: Hallmarks of systemic disease[J]. Cell, 2024, 187(7): 1589-1616.
[3] YIZHAK K, AGUET F, KIM J, et al. RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues[J]. Science, 2019, 364(6444): eaaw0726.
[4] BURRELL R A, MCGRANAHAN N, BARTEK J, et al. The causes and consequences of genetic heterogeneity in cancer evolution[J]. Nature, 2013, 501(7467): 338-345.
[5] VOGELSTEIN B, PAPADOPOULOS N, VELCULESCU V E, et al. Cancer genome landscapes[J]. Science, 2013, 339(6127): 1546-1558.
[6] BUSSEY K J, CISNEROS L H, LINEWEAVER C H, et al. Ancestral gene regulatory networks drive cancer[J]. Proc Natl Acad Sci USA, 2017, 114(24): 6160-6162.
[7] MARTINCORENA I, CAMPBELL P J. Somatic mutation in cancer and normal cells[J]. Science, 2015, 349(6255): 1483-1489.
[8] FIALA C, DIAMANDIS E P. Mutations in normal tissues-some diagnostic and clinical implications[J]. BMC Med, 2020, 18(1):283.
[9] GOMES A P, ILTER D, LOW V, et al. Age-induced accumulation of methylmalonic acid promotes tumour progression[J]. Nature, 2020, 585(7824): 283-287.
[10] SPRENGER C C, PLYMATE S R, REED M J. Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression[J]. Int J Cancer, 2010, 127(12): 2739-2748.
[11] PALMER S, ALBERGANTE L, BLACKBURN C C, et al. Thymic involution and rising disease incidence with age[J]. Proc Natl Acad Sci USA, 2018, 115(8): 1883-1888.
[12] PEREGO S, SANSONI V, ZIEMANN E, et al. Another weapon against cancer and metastasis: physical-activity-dependent effects on adiposity and adipokines[J]. Int J Mol Sci, 2021, 22(4): 2005.
[13] PEDERSEN L, IDORN M, OLOFSSON G H, et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution[J]. Cell Metab, 2016, 23(3): 554-562.
[14] CAO L, LIU X L, LIN E D, et al. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition[J]. Cell, 2010, 142(1): 52-64.
[15] YANG Y L, LIU L, WANG Y, et al. The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis[J]. BMC Cancer, 2013, 13: 393.
[16] CURRIER M B, NEMEROFF C B. Depression as a risk factor for cancer: from pathophysiological advances to treatment implications[J]. Annu Rev Med, 2014, 65: 203-221.
[17] SPIEGEL D, BLOOM J R, KRAEMER H C, et al. Effect of psychosocial treatment on survival of patients with metastatic breast cancer[J]. Lancet, 1989, 2(8668): 888-891.
[18] HU Z, DING J, MA Z C, et al. Quantitative evidence for early metastatic seeding in colorectal cancer[J]. Nat Genet, 2019, 51(7): 1113-1122.
[19] JACKLIN C, PHILIPPOU Y, SF B, et al. “More men die with prostate cancer than because of it”—an old adage that still holds true in the 21st century[J]. Cancer Treat Res Commun, 2021, 26: 100225.
[20] WELCH H G, BLACK W C. Overdiagnosis in cancer[J]. JNCI J Natl Cancer Inst, 2010, 102(9): 605-613.
[21] LóPEZ-OTíN C, PIETROCOLA F, ROIZ-VALLE D, et al. Meta-hallmarks of aging and cancer[J]. Cell Metab, 2023, 35(1): 12-35.
[22] KHAN S Y, BAH T, LAYEEQUR RAHMAN R. The role of molecular profiling in de-escalation of toxic therapy in breast cancer[J]. Int J Mol Sci, 2025, 26(3): 1332.
[23] SHAH C, WHITWORTH P, VICINI F A, et al. The clinical utility of a 7-gene biosignature on radiation therapy decision making in patients with ductal carcinoma in situ following breast-conserving surgery: an updated analysis of the DCISionRT? PREDICT study[J]. Ann Surg Oncol, 2024, 31(9): 5919-5928. |
